Compare ALG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | EVO |
|---|---|---|
| Founded | 1955 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.1B |
| IPO Year | 1993 | 2021 |
| Metric | ALG | EVO |
|---|---|---|
| Price | $172.22 | $3.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $225.00 | $7.00 |
| AVG Volume (30 Days) | 120.5K | ★ 259.6K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.64 | N/A |
| Revenue | ★ $1,615,388,000.00 | $887,396,457.00 |
| Revenue This Year | $1.26 | N/A |
| Revenue Next Year | $5.09 | $8.52 |
| P/E Ratio | $18.01 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $156.30 | $2.84 |
| 52 Week High | $233.29 | $5.10 |
| Indicator | ALG | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 50.69 |
| Support Level | $170.04 | $2.87 |
| Resistance Level | $176.42 | $3.05 |
| Average True Range (ATR) | 4.44 | 0.10 |
| MACD | 0.86 | 0.03 |
| Stochastic Oscillator | 59.23 | 72.97 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.